Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic vs Reference Imatinib 400 mg Under Fed Conditions in Healthy Thai Volunteers
TCTR20250812002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of imatinib (2 arms), sponsored by Bio-innova. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Beyond the preview
Go deeper on TCTR20250812002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250812002.